113
Treatment of cystic lesions of the jaw: a five-year
retrospective study
C. Sacher
∗
, G. Sperl, C. Perisanidis, R. Seemann, D. Holzinger
Department of Oral and Maxillofacial Surgery, Medical
University of Vienna, Vienna, Austria
Background:
Cystic lesions of the jaw are common patholo-
gies in the oral region, which may develop from epithelium with
dentogenic origin (odontogenic cysts). Depending on their size,
odontogenic cysts are usually treated either by enucleation and
closure of the defect (cystectomy) or by decompression therapy
(cystostomy or marsupialisation). Even though cystic lesions are
common and many retrospective analyses were conducted, there
are only a few prospective clinical trials
. 1,2Objectives:
This retrospective study was conducted to evaluate
the incidence, dimension, location and the chosen therapy of the
odontogenic cysts at the Department of Oral and Maxillofacial
Surgery (Medical University of Vienna). These results are used
for the planning of prospective studies.
Methods:
All patients with cystic lesions, who were treated within
five years at the Department of Oral and Maxillofacial Surgery of
the Medical University of Vienna, were included. Clinical data
included gender, age, localisation, histological diagnosis, chosen
therapy and follow-up. Radiologic data from all available radio-
graphs (panoramic radiographs, computed tomography scans,
digital volume tomography) included localisation and dimensions.
Findings and Conclusion:
A total of 899 patients were treated in
this time period. 117 patients had to be excluded due to incomplete
data. 782 patients were assessed, 106 patients were treated by
cystostomy; 745 patients by cystectomy.
Reference
Wakolbinger, R., & Beck-Mannagetta, J. (2016). Long-term results after
treatment of extensive odontogenic cysts of the jaws: a review.
Clin Oral
Investig
,
20
, 15–22.
Ettl, T., Gosau, M., Sader, R., & Reichert, T. E. (2012). Jaw cysts - filling
or no filling after enucleation? A review.
J Craniomaxillofac Surg
,
40
,
485–493.
http://dx.doi.org/10.1016/j.ijom.2017.02.397Clonidine as vasoconstrictor with lignocaine for intraoral
anaesthesia in patients with hypertension
J. Samson
∗
, A. Julius, R. Sree
Tagore Dental College and Hospital, Chennai, India
Background:
Local block anaesthesia achieved with an
adrenaline containing solution can lead to an increase in plasma
adrenaline with significant and non-significant cardiovascular
changes. Clinical studies have suggested that clonidine might have
haemodynamic advantages over adrenaline as a vasoconstrictor
because of its central hypotensive effect.
Objectives:
The objectives of this study is to evaluate the efficacy
of clonidine as vasoconstrictor, to check any changes in haemody-
namic parameters and also to find out the onset, duration, intensity
of local anaesthesia.
Methods:
Study included 280 patients of ASA II group,
aged 40–70 years, for extraction of mandibular teeth. Patients
received 2 mL of 2% lidocaine with clonidine in concentration
of 15 mg/mL. Systolic blood pressure, diastolic blood pressure,
mean arterial pressure, heart rate, were recorded before, during,
5 min after administration of anaesthesia, during extraction, and
10 min after extraction.
Findings:
One way repeated measure analysis of variance was
done using SPSS Vs 20. There is a significant difference in the
haemodynamic parameters during different duration of anaesthe-
sia.
Conclusion:
Clonidine when used with lignocaine as vasocon-
strictor for intraoral anaesthesia in hypertensive patients brought
about a reduction in the blood pressure retaining all the properties
of lignocaine.
http://dx.doi.org/10.1016/j.ijom.2017.02.398Risk of osteonecrosis of the jaws after tooth extraction of 270
teeth with alveolectomy and primary surgical closure in 111
patients on antiresorptive treatment
M. Schiodt
∗
, C. Ottesen, S. Madsen, E. Nielsen, L. Sand,
C. Gjoedesen
Department of Oral and Maxillofacial Surgery, Copenhagen
University Hospital, Copenhagen, Denmark
Background:
Tooth extraction often precedes onset of
medication-related osteonecrosis of the jaws (MRONJ) in patients
on antiresorptive treatment (AR). Limited data exist on the risk
of high dose bisphosphonate and denosumab. We have devel-
oped a method of tooth extraction with primary closure which
is associated with a low risk of developing MRONJ.
Objectives:
To examine the incidence of MRONJ after tooth
extraction in consecutive patients on AR referred for tooth extrac-
tion.
Methods:
Inclusion criteria: patients referred for tooth extraction
on AR. Patients were evaluated with medical history, duration
of AR, clinical and radiologic assessment. The surgical procedure
included raising mucosal flap, alveolectomy, removal of the tooth,
and primary mucosal closure. Assessment for MRONJ after one
and three months.
Findings:
One hundred and eleven patients (22 osteoporosis,
89 cancer) were referred for extraction of 270 teeth. AR treat-
ment included bisphosphonate in 70% and denosumab in 39%.
Mean duration of treatment was 45 months for bisphosphonate,
21 months for denosumab. Healing was uneventful in 267 extrac-
tion sites (99% [95% CI, 97–100]) in 108 patients of the 111
patients (97% [95% CI, 92–99]). Thus, osteonecrosis occurred in
three sites (1%), in three patients (3%), all three with breast cancer.
Conclusion:
Tooth extraction with alveolectomy and primary
closure of the oral mucosa is a useful method for controlling
(nearly eliminating) the risk of MRONJ in patients on high dose
antiresorptive treatment. Tooth extractionwas performedwith suc-
cessful healing in 99% of 267 extractions sites and in 97% of 111
patients.
http://dx.doi.org/10.1016/j.ijom.2017.02.399




